Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ National Healthcare Corporation (NHC) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Medical Care Facilities
$100.55
+5.89 (6.22%)10 Quality Stocks Worth Considering Now
Researching NHC (NHC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on NHC and similar high-potential opportunities.
NHC has shown a year-to-date change of -6.5% and a 1-year change of 5.9%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for NHC. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for NHC.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to NHC based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
National Healthcare Corporation has a market capitalization of $1.55B with a P/E ratio of 14.5x. The company generates $1.30B in trailing twelve-month revenue with a 7.9% profit margin.
Revenue growth is +25.3% quarter-over-quarter, while maintaining an operating margin of +7.8% and return on equity of +10.8%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Provides comprehensive senior care services.
The company operates private healthcare facilities, generating revenue through a range of services including skilled nursing, assisted living, and home care, primarily catering to the long-term care needs of the elderly. By integrating various services and care models, National Healthcare Corporation creates a continuum of care that enhances patient outcomes and drives consistent revenue streams.
NHC's extensive network of healthcare centers and rehabilitation facilities positions it as a significant player in the healthcare sector, directly addressing the rising demand for quality long-term care services among an aging population. Its operations also influence local healthcare infrastructure and contribute to broader discussions on healthcare policy.
Healthcare
Medical Care Facilities
14,962
Dr. Stephen Fowler Flatt
United States
1987
National HealthCare Corporation (NHC) will pay a quarterly dividend of 64 cents per share on August 1, 2025, a 4.9% increase from the previous quarter. Shareholders must be on record by June 30, 2025.
The 4.9% dividend increase signals financial health and growth potential for National HealthCare Corporation, enhancing its attractiveness to income-focused investors.
National HealthCare Corporation reported Q1 2025 net operating revenues of $373.7 million, up 25.7% from $297.2 million in Q1 2024, driven by an 8.5% increase in same-facility net operations.
National HealthCare Corporation's 25.7% revenue increase signals strong growth and operational efficiency, potentially enhancing investor confidence and stock performance.
National HealthCare Corporation announced that W. Andrew Adams will retire from its Board of Directors effective May 8, 2025.
W. Andrew Adams' retirement from the NHC Board may signal upcoming changes in leadership or strategy, potentially affecting company direction and investor confidence.
Kaskela Law LLC is investigating National HealthCare Corporation (NYSE: NHC) on behalf of its long-term investors, as announced on April 7, 2025.
The investigation into National HealthCare Corporation could signal potential legal or regulatory issues, impacting stock performance and investor confidence.
National Healthcare Properties, Inc. declared a quarterly dividend of $0.4609375 per share on its 7.375% Series A Preferred Stock, payable on April 15, 2025, to holders of record by April 4, 2025.
NHP's dividend declaration signals financial stability and commitment to returning value to shareholders, potentially attracting income-focused investors and influencing stock price.
National HealthCare Corporation (NHC) reported a 14.5% increase in net operating revenues for 2024, totaling $1.31 billion, driven by a 9.4% rise in same-facility operations.
National HealthCare Corporation's 14.5% revenue growth signals strong performance and operational efficiency, potentially leading to increased investor confidence and stock value.
Analyst forecasts for National Healthcare Corporation (NHC) are not currently available. The stock is trading at $100.55.
Analyst ratings for NHC are not currently available. The stock is currently trading at $100.55. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for NHC are not currently available. The stock is trading at $100.55.
The company operates private healthcare facilities, generating revenue through a range of services including skilled nursing, assisted living, and home care, primarily catering to the long-term care needs of the elderly. By integrating various services and care models, National Healthcare Corporation creates a continuum of care that enhances patient outcomes and drives consistent revenue streams.
Price targets from Wall Street analysts for NHC are not currently available. The stock is trading at $100.55.
Price targets from Wall Street analysts for NHC are not currently available. The stock is trading at $100.55.
Analyst ratings for NHC are not currently available. The stock is trading at $100.55.
Stock price projections, including those for National Healthcare Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.